论文部分内容阅读
目的探讨肝硬化顽固性腹水的临床特点和治疗效果。方法选择本院2007年3月至2009年3月肝硬化难治性腹水患者42例,分析其临床资料。本组病例中,31例患者采用以上一般治疗;5例患者出现自发性细菌性腹膜炎给予抗生素治疗;6例患者无自发性细菌性腹膜炎,采用自身腹水超滤浓缩技术自体腹水回输。结果本组患者经过3周治疗后,其中显效25例,占59.2%,有效12例,占28.5%,无效3例,占7.1%,死亡2例,均为肝癌患者,在临床治疗中出现肝肾综合征,患者因肝性脑病而死亡。结论在临床治疗中,通过查找肝硬化腹水治疗失败的原因,采用综合疗法治疗顽固性腹水,疗效显著,值得借鉴。
Objective To investigate the clinical features and therapeutic effects of refractory cirrhosis and ascites. Methods Forty-two patients with cirrhosis refractory ascites from March 2007 to March 2009 were selected and their clinical data were analyzed. In this group of patients, 31 patients with the above general treatment; 5 patients with spontaneous bacterial peritonitis treated with antibiotics; 6 patients without spontaneous bacterial peritonitis, ascites using autologous ascites ultrafiltration concentration of autologous transfusion. Results In this group of patients after 3 weeks of treatment, which markedly effective in 25 cases, accounting for 59.2%, 12 cases were effective, accounting for 28.5%, 3 cases were ineffective, accounting for 7.1%, 2 patients died of liver cancer patients in the clinical treatment of liver Kidney syndrome, the patient died of hepatic encephalopathy. Conclusion In the clinical treatment, by looking for the cause of liver cirrhosis ascites failure, the treatment of intractable ascites with comprehensive therapy, the effect is significant, it is worth learning from.